Maximum tolerated dose (MTD) and safety profile from phase I study of MT-3724 (CD20 targeted immunotoxin) in relapsed/refractory (R/R) non-Hodgkin B-cell lymphoma (NHL) Meeting Abstract

  

Authors:	Fanale, M. A.; Park, S. I.; Valacer, D. J.; Higgins, J.; Sloan, J. M.; Younes, A.; Hamlin, P. A.
Abstract Title:	Maximum tolerated dose (MTD) and safety profile from phase I study of MT-3724 (CD20 targeted immunotoxin) in relapsed/refractory (R/R) non-Hodgkin B-cell lymphoma (NHL)
Meeting Title:	59th Annual Meeting of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	130
Issue:	Suppl. 1
Meeting Dates:	2017 Dec 9-12
Meeting Location:	Atlanta, GA
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2017-12-07
Language:	English
ACCESSION:	WOS:000432419705389
PROVIDER:	wos
DOI:	10.1182/blood.V130.Suppl_1.5212.5212
Notes:	Meeting Abstract: 5212 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/127048